Chrysos Corporation Limited (ASX:C79) develops and supplies innovative assay technologies and services for the global mining industry, combining science and software to deliver faster, safer, more accurate, and environmentally friendly analysis of gold, silver, copper, and other elements. The company's flagship product, PhotonAssay, a proprietary chemistry-free technology originally developed by Australia's CSIRO, enables quantitative detection using large sample sizes up to 500g with results in as little as two minutes; it supports automated operations, reduced sample preparation, lower labor requirements, and non-destructive testing for subsequent analyses such as metallurgical or environmental assessments. Chrysos operates through geographic segments including EMEA, Australia, Americas, and recently Latin America, serving major mining companies and laboratories with lease agreements, master services agreements, and direct deployments across four to five continents. Founded in 2016 and headquartered in Tonsley, South Australia, the company targets gold miners and explorers dealing with coarse gold mineralization, providing operational data to optimize ore body analysis and value chain decisions. Recent developments include a September 2025 strategic partnership with Bureau Veritas for its first PhotonAssay unit deployment in Antofagasta, Chile, marking entry into Latin America; a May 2025 master services agreement and lease contract with Newmont for installation at the Ahafo mine in Ghana, followed by an additional lease for the Merian mine in Suriname; and ongoing expansions from prior partnerships such as the 2023 global alliance with Barrick Gold and MSALABS for deployments across multiple continents.